Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Consultation on the Prescription Drug List: Naloxone The purpose of this Notice of Consultation is to provide an opportunity to comment on the proposal to revise the qualifier for Naloxone on the Prescription Drug List (PDL). How to Get Involved This consultation is open for…
Consultation on the Prescription Drug List: Hydroquinone The purpose of this Notice of Consultation is to provide an opportunity to comment on the proposal to add hydroquinone to the Prescription Drug List (PDL) when sold in a concentration greater than 2% in topical products.…
Notice: Prescription Drug List (PDL): Multiple additions [2017-08-04] August 4, 2017 Our file number: 17-108135-629 The purpose of this Notice of Amendment is to notify the additions of Cysteamine (Mercaptamine) and Nusinersen to the Human and Veterinary Prescription Drug Lists…
Notice: Prescription Drug List (PDL): Human and Veterinary Antimicrobials December 15, 2017 Our file number: 17-113103-789 This follows the July 5, 2017 Notice of Consultation regarding the amendment of 14 antimicrobial active ingredients or their salts or derivatives from…
Notice of intent to amend: Prescription Drug List (PDL): Phytocannabinoids July 11, 2018 Our file number: 18-107455-965 The purpose of this Notice of Intent to Amend is to announce that Health Canada will add phytocannabinoids to the Human and Veterinary Prescription Drug Lists…
Notice: Prescription Drug List (PDL): Multiple additions [2018-07-25] July 25 th , 2018 Our file number: 18-109017-258 The purpose of this Notice of Amendment is to notify about the additions of: Calcifediol, Tezacaftor, and Apalutamide to the Human and Veterinary Prescription…
Notice: Prescription Drug List (PDL) Multiple Additions 08-16-2018 August 16, 2018 Our file number: 18-109655-207 The purpose of this Notice of Amendment is to notify about the additions of Brigatinib, Bictegravir and Hemin to the Human and Veterinary Prescription Drug List…
Notice: Prescription Drug List (PDL): Nicotine Qualifier Clarification August 23, 2018 Our file number: 18-108495-631 The purpose of this Notice of Amendment is to notify that Health Canada is clarifying the nicotine qualifier entry on the PDL. Only the qualifier for human use is…
Notice: Prescription Drug List (PDL): Multiple additions October 1 st , 2018 Our file number: 18-112049-187 The purpose of this Notice of Amendment is to notify about the additions of: Baricitinib, Emicizumab, Erenumab, Tisagenlecleucel and Dalbavancin to the Prescription Drug…
Notice - Prescription Drug List (PDL): Hydroquinone October 1, 2018 Our file number: 18-110017-372 The purpose of this Notice of Amendment is to notify about the addition of hydroquinone or its derivatives to the Prescription Drug List (PDL) for human use when sold in…
Early release: coverage and features are still expanding.
